Editorial & Opinion
Anti-tumour necrosis factor-associated cutaneous leishmaniasis: a single-institution experience.
العنوان: | Anti-tumour necrosis factor-associated cutaneous leishmaniasis: a single-institution experience. |
---|---|
المؤلفون: | Martínez-Doménech A; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., García-Legaz-Martínez M; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Magdaleno-Tapial J; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Torrecillas M; Department of Microbiology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Hernández-Bel P; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Ocete Mochón MD; Department of Microbiology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Pérez-Ferriols A; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., de Miquel VA; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain. |
المصدر: | The British journal of dermatology [Br J Dermatol] 2019 Aug; Vol. 181 (2), pp. 403-405. Date of Electronic Publication: 2019 May 06. |
نوع المنشور: | Letter |
اللغة: | English |
بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
أسماء مطبوعة: | Publication: 2023- : Oxford : Oxford University Press Original Publication: Oxford [etc.] Published for the British Association of Dermatologists by Blackwell Scientific Publications [etc.] |
مواضيع طبية MeSH: | Immunosuppressive Agents/*adverse effects , Leishmaniasis, Cutaneous/*diagnosis , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Adult ; Aged ; DNA, Protozoan/isolation & purification ; Female ; Humans ; Leishmania donovani/genetics ; Leishmania donovani/isolation & purification ; Leishmania infantum/genetics ; Leishmania infantum/isolation & purification ; Leishmaniasis, Cutaneous/immunology ; Leishmaniasis, Cutaneous/parasitology ; Leishmaniasis, Cutaneous/pathology ; Male ; Middle Aged ; Skin/parasitology ; Skin/pathology ; Tumor Necrosis Factor-alpha/immunology ; Young Adult |
المشرفين على المادة: | 0 (DNA, Protozoan) 0 (Immunosuppressive Agents) 0 (TNF protein, human) 0 (Tumor Necrosis Factor-alpha) |
تواريخ الأحداث: | Date Created: 20190120 Date Completed: 20200930 Latest Revision: 20200930 |
رمز التحديث: | 20231215 |
DOI: | 10.1111/bjd.17644 |
PMID: | 30659588 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1365-2133 |
---|---|
DOI: | 10.1111/bjd.17644 |